| Item | Value |
|---|---|
| DrugBank ID | DB06643 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 30 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | osteoporosis | TxGNN Knowledge Graph |
| 2 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 3 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 4 | osteoporosis | TxGNN Knowledge Graph |
| 5 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 6 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 7 | osteoporosis | TxGNN Knowledge Graph |
| 8 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 9 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 10 | osteoporosis | TxGNN Knowledge Graph |
| 11 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 12 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 13 | osteoporosis | TxGNN Knowledge Graph |
| 14 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 15 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 16 | osteoporosis | TxGNN Knowledge Graph |
| 17 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 18 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 19 | osteoporosis | TxGNN Knowledge Graph |
| 20 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 21 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 22 | osteoporosis | TxGNN Knowledge Graph |
| 23 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 24 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 25 | osteoporosis | TxGNN Knowledge Graph |
| 26 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 27 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
| 28 | osteoporosis | TxGNN Knowledge Graph |
| 29 | drug-induced osteoporosis | TxGNN Knowledge Graph |
| 30 | postmenopausal osteoporosis | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.